After graduating from Zhejiang University School of Medicine in July 2010, Dr. HU Hong has engaged in medical oncology at SRRSH, specializing in the comprehensive diagnosis and treatment of various common malignant tumors, tumor immunity and targeted therapy, tumor radiofrequency ablation therapy, and clinical research on new tumor drugs. He has participated in more than 30 domestic and foreign multi-center clinical research on new anti-tumor drugs, led and participated in a number of provincial and municipal projects.

Member of the Anti-Tumor Drug Safety Management Committee of the Chinese Clinical Oncology Society (CSCO)

Member of the Precision Medicine Branch of the China Medical Biotechnology Association

Member of the Special Committee of Tumor Physical Therapy of Zhejiang province

Member of the Youth Committee of the Tumor Precision Therapy Professional Committee of the Zhejiang Medical Association